glp-1-based treatments approved for weight loss 2025 GLP-1 Pipeline Update: August - Prime Therapeutics GLP-1 rec agonists have evolved
Description
This is relevant because many clinics (and all telehealth services) use NPs and PAs as primary prescribers
A poll released Friday by KFF found that about 1 in 8 adults say they are currently taking a GLP-1 drug to treat a chronic disease, for weight loss or both an increase of 6% since May 2024

A Brief Recap: Why This Matters For readers encountering this topic for the first time, the underlying issue is worth restating briefly

TrimRx connects Louisiana patients with doctors who prescribe Wegovy online and create safe treatment plans

Both may be helpful for the right patient and inappropriate for another

GLP-1 Stickers public service announcement